Healthcare’s poor data infrastructure is hindering AI innovation

Healthcare AI progress could soon stall due to fragmented, inaccessible data systems, warned OMNY Health CEO Mitesh Rao. He said that scalable AI requires a more interoperable data infrastructure — and without it, even it will be difficult for advanced AI solutions to succeed.

Editor's Pick

Top Story Healthcare's Poor Data Infrastructure Is Hindering AI Innovation in the Field, CEO Says Healthcare AI progress could soon stall due to fragmented, inaccessible data systems, warned OMNY Health CEO Mitesh Rao. He said that scalable AI requires a more interoperable data infrastructure — and without it, even it will be difficult for advanced AI solutions to succeed. Sponsored Revolutionize Your Maternity Case Management – See the Integrated Solution Driving Results Presented by Progeny Health Progeny Health reveals how leading health plans are transforming maternal and infant care with a fully integrated, tech-enabled solution. Learn how personalized case management, early risk identification, and NICU optimization are reducing preterm births, improving health equity, and cutting costs. This report is a must-read for payers and employers looking to drive better outcomes across the maternity journey. 👉 Download now to see how you can improve outcomes and lower costs—starting today. Join Healthcare's Boldest Leaders at HLTH USA 2025 This October Presented by HLTH Hurry, prices increase on Friday, August 8! Lock in your spot at healthcare's most influential event and save 25%+, that's over $1,000 off your HLTH USA pass.

Featured News

HealthTap Introduces Direct Virtual Primary Care Program With HealthTap's new direct virtual primary care program, members get ongoing access to a primary care doctor of their choosing through video visits and messaging. Sarepta's Future in Gene Therapy Remains Clouded, But Data From Partner Hansa Is a Bright Spot Hansa Biopharma has encouraging early clinical results showing its drug imlifidase, used as a pretreatment, enabled Duchenne muscular dystrophy patients to receive the gene therapy Elevidys. Sarepta is searching for ways to mitigate excessive immune responses to Elevidys that can lead to serious and potentially fatal liver injury. Carving a Path Toward Pragmatic Innovation in Clinical Trials Prioritizing risk-based management, data science, smart automation, standards, and patient optionality are critical for the industry to keep up with market changes. The recent FDA guidance that encourages 'pragmatic trials' in specific scenarios is a move in the right direction. The Future of Glucose Monitoring: Why Blood-Based Measurements Matter Today, people living with diabetes have several ways of monitoring glucose levels, whether through finger pricks or CGMs. Both ways of measuring glucose levels have benefits and limitations.

Video   Future of U.S. Preventive Services Task Force in Jeopardy RFK Jr. is reportedly considering eliminating the U.S. Preventive Services Task Force, which provides recommendations about clinical preventive services like screenings, counseling services and preventive medications. This is concerning several industry groups, including the American Medical Association.

Sponsored Expert Care in Houston: Top-Rated Hand and Wrist Surgeons You Can Trust Presented by Fondren Orthopedic Group Too many people sacrifice their quality of life by putting off a surgical procedure. Discover the top-rated hand and wrist surgeons in the Houston area who can help. Learn More.

Resources

MedCity Pivot Podcast: How the Right Payment Tech Can Foster Better Payer-Provider Relationships Yusuf Qasim, president of payments optimization at Zelis, talks about how his company's platform is seeking to rebuild the healthcare payment process. The platform aims to eliminate unnecessary manual work for both payers and providers. Watch or listen now!

MedCity News • PO Box 901 • New York, NY unsubscribe